...
首页> 外文期刊>International Journal of Nanomedicine >Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A
【24h】

Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A

机译:油包水型微乳作为羟基红花黄色素A的口服给药体系的增强作用和机理

获取原文

摘要

Background: A microemulsion is an effective formulation for improving the oral bioavailability of poorly soluble drugs. In this paper, a water-in-oil (w/o) microemulsion was investigated as a system for enhancing the oral bioavailability of Biopharmaceutic Classification System (BCS) III drugs.Methods: The microemulsion formulation was optimized using a pseudoternary phase diagram, comprising propylene glycol dicaprylocaprate (PG), Cremophor? RH40, and water (30/46/24 w/w).Results: The microemulsion increased the oral bioavailability of hydroxysafflor yellow A which was highly water-soluble but very poorly permeable. The relative bioavailability of hydroxysafflor yellow A microemulsion was about 1937% compared with a control solution in bile duct-nonligated rats. However, the microemulsion showed lower enhanced absorption ability in bile duct-ligated rats, and the relative bioavailability was only 181%. In vitro experiments were further employed to study the mechanism of the enhanced effect of the microemulsion. In vitro lipolysis showed that the microemulsion was digested very quickly by pancreatic lipase. About 60% of the microemulsion was digested within 1 hour. Furthermore, the particle size of the microemulsion after digestion was very small (53.3 nm) and the digested microemulsion had high physical stability. An everted gut sac model demonstrated that cumulative transport of the digested microemulsion was significantly higher than that of the diluted microemulsion.Conclusion: These results suggested that digestion of the microemulsion by pancreatic lipase plays an important role in enhancing oral bioavailability of water-soluble drugs.
机译:背景:微乳剂是改善难溶性药物口服生物利用度的有效制剂。本文研究了油包水型(w / o)微乳作为增强生物制药分类系统(BCS)III药物口服生物利用度的系统。丙二醇二辛酸酯(PG),Cremophor吗? RH40和水(30/46/24 w / w)。结果:微乳提高了水溶性高但渗透性差的羟基红花黄A的口服生物利用度。与未用胆管结扎的大鼠的对照溶液相比,羟基红花黄色素A微乳剂的相对生物利用度约为1937%。然而,微乳剂在结扎胆管的大鼠中显示出较低的增强的吸收能力,并且相对生物利用度仅为181%。进一步采用体外实验来研究微乳作用增强的机理。体外脂解显示该微乳液被胰腺脂肪酶快速消化。 1小时内消解了约60%的微乳液。此外,消化后的微乳液的粒径非常小(53.3nm),并且消化的微乳液具有高的物理稳定性。外翻肠囊模型表明消化后的微乳液的累积转运量明显高于稀释后的微乳液。结论:这些结果表明,胰脂肪酶对微乳液的消化在提高水溶性药物的口服生物利用度方面起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号